Monrovia, Liberia – A detailed independent inquiry by Heritage Newspaper has concluded that the 2025 Performance Excellence Award bestowed upon the National Public Health Institute of Liberia reflects the foundational work executed under Director General Dougbeh Chris Nyan, rather than initiatives undertaken during the current interim administration.
The award, presented by President Joseph Nyuma Boakai, recognizes institutional performance over the 2024–2025 review periods a timeframe that substantially overlaps with Dr. Nyan’s tenure prior to his controversial removal in October 2025.
The Performance Excellence Award covers the period under review from January 2025 to June 12, 2025 through December 31, 2025. It also comes as a result of the Performance Management Contract signed and implemented by Dr. Nyan and his Team. It covers the period under review from January 2025 to June 12, 2025 through December 31, 2025.
Despite the significance of this recognition, the investigation finds that the contributions of Dr. Nyan has not been prominently acknowledged by the interim leadership headed by Sia Wata Carmanor. Multiple sources within the public health sector indicate that the performance metrics underpinning the award were achieved through reforms, innovations, and capacity-building measures initiated well before the leadership transition.
Under Dr. Nyan’s administration, NPHIL recorded measurable gains in laboratory expansion, disease surveillance, and administrative efficiency key indicators cited in national performance evaluations. One of the most notable achievements during his tenure was NPHIL’s designation by the Africa Centres for Disease Control and Prevention as a Regional Centre of Excellence for National Public Health Institute development.
This prestigious recognition followed a rigorous continental assessment and positioned Liberia as a leader in strengthening public health systems across Africa. In a formal communication dated January 31, 2025, Africa CDC Director-General Jean Kaseya extended the designation, citing NPHIL’s technical leadership and commitment to advancing disease control mechanisms.
The Centre of Excellence status aligns with the African Union’s Agenda 2063, underscoring Liberia’s role in regional health security and institutional development. Experts note that achieving such status requires sustained institutional performance, advanced scientific capacity, and credible leadership conditions that were cultivated during Dr. Nyan’s administration.
Among the reforms introduced were the establishments of three pilot regional laboratories, significantly improving access to diagnostic services across the country. Disease surveillance systems were also strengthened, including cross-border monitoring frameworks designed to detect and respond to emerging health threats more effectively.
The introduction of genomic sequencing technology further enhanced Liberia’s capability to identify and track pathogens with precision. Administrative restructuring at NPHIL improved operational workflows, accountability mechanisms, and overall institutional discipline. An independent assessment by the General Auditing Commission recorded an 81 percent performance score for NPHIL under Dr. Nyan marked a substantial increase compared to previous administrations.
These documented achievements have fueled public debate over the characterization of Dr. Nyan’s leadership was “inefficient,” a claim that formed the basis of his dismissal. The controversy deepened following a ruling by the Supreme Court of Liberia, which declared the termination unlawful and inconsistent with both statutory and constitutional provisions.
In its February 16, 2026 decision, delivered by Associate Justice Jamesetta Howard Wolokollie, the Court ordered Dr. Nyan’s reinstatement or compensation for the remainder of his tenure. The ruling found no evidence of a legitimate investigation to support allegations of misconduct or inefficiency.
Legal experts have described the judgment as a landmark affirmation of due process and judicial authority in Liberia’s governance framework. Despite the clarity of the Court’s directive, its implementation remains pending, raising concerns about compliance within the Executive Branch.
Officials at the Ministry of Justice are reported to have formally advised the Executive Mansion on the legal implications of non-adherence to the ruling. The Court’s decision also placed restrictions on the authority of the interim leadership at NPHIL, intensifying scrutiny over ongoing administrative actions.
Meanwhile, analysts continue to question the lack of recognition accorded to Dr. Nyan for achievements that have garnered both national and international acclaim. Beyond institutional reforms, Dr. Nyan is globally recognized for scientific innovation, including the development of the NYAN-TEST pathogen detection system.
His contributions have earned him multiple international honors, reinforcing his standing within the global public health community. Within Liberia, many see the current situation as a broader test of governance, institutional accountability, and respect for the rule of law.
Public discourse has increasingly emphasized the need for transparency and fairness in acknowledging contributions to national development. For stakeholders in the health sector, the issue extends beyond individual recognition to the integrity of public institutions.
As the debate continues, attention remains focused on how the government will reconcile the Court’s ruling with ongoing administrative realities. What is clear, however, is that the performance record underpinning NPHIL’s 2025 award has reignited national conversation about leadership, accountability, and the enduring impact of Dr. Nyan’s tenure.
Credit: Figo Mansaray
